相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Renal Effects after Pembrolizumab Treatment for Non-small Cell Lung Carcinoma
Rikako Oki et al.
INTERNAL MEDICINE (2020)
Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review
Meghan E. Sise et al.
ONCOLOGIST (2019)
Acute Tubulointerstitial Nephritis: A Case Report on Rare Adverse Effect of Pembrolizumab
Sijan Basnet et al.
MEDICINA-LITHUANIA (2019)
Renal Vasculitis and Pauci-immune Glomerulonephritis Associated With Immune Checkpoint innioitors
Alexander J. Gallan et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
Martin Reck et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 ≥50% who progress on first-line immunotherapy: real-world data from a European cohort
Giulio Metro et al.
JOURNAL OF THORACIC DISEASE (2019)
Renal toxicities associated with pembrolizumab
Hassan Izzedine et al.
CLINICAL KIDNEY JOURNAL (2019)
Anti - PD-1 Immunotherapy May Induce Interstitial Nephritis With Increased Tubular Epithelial Expression of PD-L1
Clarissa Cassol et al.
KIDNEY INTERNATIONAL REPORTS (2019)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency
Ramy M. Hanna et al.
CASE REPORTS IN NEPHROLOGY AND DIALYSIS (2018)
Adverse kidney effects of epidermal growth factor receptor inhibitors
Hassan Izzedine et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer Patients
Anushree C. Shirali et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Pembrolizumab-associated minimal change disease in a patient with malignant pleural mesothelioma
Angelika Bickel et al.
BMC CANCER (2016)
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
Frank B. Cortazar et al.
KIDNEY INTERNATIONAL (2016)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
分享论文
